Alnylam Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2830 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Oracle upgraded, Reddit downgraded: Wall Street's top analyst calls - Nov 2nd, 2026 7:55 am
Should You Buy The Dip In Alnylam Stock? - Nov 2nd, 2026 7:39 am
Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience - Nov 2nd, 2026 7:00 am
Buy, Sell, or Hold? Today’s Top Upgrades and Downgrades: Amazon.com, Coinbase Global, CrowdStrike, FormFactor, GameStop, L3Harris Technologies, Oracle, Reddit, Rivian Automotive, and More - Nov 2nd, 2026 6:13 am
FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight - Nov 2nd, 2026 3:36 am
5 Best High Growth Stocks Outside Big Tech - Oct 31st, 2026 3:39 pm
Alnylam (ALNY) Stock Drops As Q3 Earnings Clash With Sales Concerns - Oct 30th, 2026 10:21 pm
BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS Says - Oct 30th, 2026 11:04 am
Alnylam Pharmaceuticals' Fundamentals Remain Strong Despite Lower-End Guidance Expectations, UBS Says - Oct 30th, 2026 11:00 am
What Just Happened To Alnylam Stock? - Oct 30th, 2026 10:51 am
Alnylam Q3 Update Disappoints as TTR Revenue Trends Toward Low End, RBC Says - Oct 30th, 2026 10:08 am
Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche - Oct 30th, 2026 8:42 am
Global Gene Silencing Therapeutics Market Report 2026-2030 | Capitalize on 16.3% CAGR as Novartis, Alnylam, Ionis, Sarepta, and Arrowhead Accelerate RNA Delivery - Oct 30th, 2026 8:38 am
ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns - Oct 30th, 2026 8:02 am
Reddit downgraded, Rivian upgraded: Wall Street's top analyst calls - Oct 30th, 2026 7:45 am
What Investors Got Wrong About Alnylam Pharmaceuticals Before A 61% Slide - Oct 29th, 2026 10:31 pm
Alnylam Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary - Oct 29th, 2026 3:09 pm
ALNY Stock Hits Fresh 52-Week Low On Medicare Access Worries And Pipeline Delays - Oct 29th, 2026 12:26 pm
Alnylam (ALNY) Q3 2026 Earnings Call Transcript - Oct 29th, 2026 11:13 am